Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2022-12-02 Report Publication Anno…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2022
Report Publication Announcement Classification · 1% confidence The document is titled "MorphoSys AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements." It explicitly states that it is a preliminary announcement regarding the disclosure dates and locations for future Quarterly/Interim statements (which would typically be classified as IR or ER/MDA). Since the document itself is not the financial report but rather an announcement about *when* and *where* the reports will be published, it fits the definition of a Report Publication Announcement (RPA). The document length is short (2266 chars), supporting the 'MENU VS MEAL' rule.
2022-12-02 English
Report Publication Announcement 2022
Report Publication Announcement Classification · 1% confidence The document is a 'Preliminary announcement of the publication of financial reports' by MorphoSys AG, detailing the future disclosure dates for the 'Annual financial report', 'Annual financial report of the group', and 'Financial report of the group (half-year/Q2)'. Crucially, the document itself is not the financial report but an announcement *about* the publication of those reports. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing the release of other reports should be classified as a Report Publication Announcement (RPA). The document length (2820 chars) supports this interpretation, as it is merely a notice providing dates and links, not the comprehensive financial data itself.
2022-12-02 English
MorphoSys AG: Financial Calendar 2023
Report Publication Announcement Classification · 1% confidence The document is titled "MorphoSys AG: Financial Calendar 2023" and explicitly lists future dates for key corporate events, including the 'Publication of Interim Statement / Report', 'Conference Call', and the 'Annual General Meeting'. This content is an announcement detailing a schedule of future corporate events rather than the actual financial report, management discussion, or voting results themselves. Since it is an announcement about future corporate events and reporting schedules, it does not fit perfectly into the specific categories like 10-K, ER, or IR. However, it is a general corporate announcement disseminated via a news service (EQS-News). Given the options, this type of scheduling announcement is best categorized as a general Regulatory Filing (RNS) or potentially related to the AGM if the focus was solely on that date, but since it covers the entire year's financial schedule, RNS is the most appropriate fallback for a miscellaneous corporate schedule announcement.
2022-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting the 'Notification of Major Holdings' by Morgan Stanley in MorphoSys AG, specifying the acquisition/disposal of shares and instruments, and detailing the resulting percentage of voting rights. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a specific regulatory filing about shareholding thresholds being crossed, not the results of a general meeting (DVA).
2022-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, specifically focusing on 'Notification of Major Holdings' as per German Securities Trading Act (WpHG). Section 6 details the 'Total positions' in terms of voting rights percentages before and after the change, and Section 7 breaks down these rights by shares and instruments. This content directly corresponds to the definition of a notification regarding changes in significant share ownership thresholds. This matches the definition for Major Shareholding Notification (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it pertains to a very specific type of ownership disclosure.
2022-11-28 English
MorphoSys AG: Krisja Vermeylen, buy
Director's Dealing Classification · 1% confidence The document explicitly states 'Directors’ Dealings' in the title and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details the name of the individual (Krisja Vermeylen), their position (Member of the administrative or supervisory body), and the nature of the transaction (Acquisition of shares). This directly corresponds to the definition of Director's Dealing, which is classified as 'DIRS'. The document length is short, but the content is the primary disclosure itself, not an announcement of a report.
2022-11-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.